Schedule 13D ownership disclosure
Inmune Bio Inc
Security class unavailable · CUSIP: 45782T105
Event date: 2020-02-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.6600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-003974
- Form type
- SC 13D
- Filer
- Inmune Bio, Inc.
- CIK
- CIK 1711754
- Filed
- Feb 14, 2020
- Reporting period
- Feb 14, 2020
- Description
- Schedule 13D beneficial ownership